Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Onconetix, Inc. (NASDAQ: ONCO) and Ocuvex Therapeutics, Inc. is fair to Onconetix shareholders. Upon completion of ...

Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held ...

Onconetix (ONCO) received a staff delisting letter from Nasdaq on May 20 indicating that the company’s failure to file its Quarterly Report Q for the three months ended March 31, ...

Onco acted as an aggregator platform for hospitals and provided online consultancy services for cancer patients. It also ...

Founded by Jain and Dr Amit Jotwani in 2016, Onco raised $13 Mn in funding from investors like Accel, Rainmatter, Alteria ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

Onco-Innovations (CBOE CA:ONCO) stated that the co-founders of its wholly-owned subsidiary, Inka Health Corp., have authored an intriguing new study ・The study addresses a critical challenge in ...

VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...

VANCOUVER, BC / ACCESS Newswire / July 10, 2025 / Onco-Innovations Limited is pleased to announce the appointment of Dr. Islam Mohamed as Chair of its Scientific and Clinical ...

VANCOUVER, BC / ACCESS Newswire / July 10, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Islam ...

VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited is pleased to announce that on July 2, 2025, its Chief Executive Officer, Thomas O'Shaughnessy, ...